Medtronic To Buy Covidien For $42.9B

Medtronic announced a $42.9 billion deal to acquire rival medical device maker Covidien, creating a formidable competitor to Johnson & Johnson's device business.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsM&A
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!